The declared intent of the EPRD was and is to create a robust framework for the assessment of hip and knee arthroplasties in the German healthcare system. And the number of procedures reported to the Registry continues to increase, as the 2020 Annual Report shows.


By the end of 2019, the commitment of the participating institutions and patients has allowed the EPRD to compile documentation on more than 1.3 million hip and knee arthroplasties. In 2019 alone, 723 hospitals submitted data sets of more than 315,000 arthroplasties to the EPRD. Of these, more than 175,000 were for hip replacements and more than 140,000 for knee replacements. Thus, in 2019 the EPRD covered 70 % of such arthroplasties performed in Germany.

By now, the EPRD is also attracting increased international attention. It is not simply the number of data sets in the EPRD, but also the product database and the structure of the data flow that have gained the EPRD positive international recognition.

The 2020 Annual Report is not only the second annual report of the EPRD in English translation but also the second annual report for which the EPRD was able to draw on the revised product database, which was developed together with the National Joint Registry (NJR) of the UK.

The present annual report adheres to the established structure of its predecessors: after a brief outline of the EPRD's development to date in Chapter 2, Chapter 3 explains how the data has been analysed. Chapter 4 describes the documentation submitted for the calendar year 2019, the current situation in patient care and looming developments. Chapter 5, the core of the report, discusses the timeline of the arthroplasty survival outcomes. This includes an assessment of the risk of (second) revision after primary arthroplasty or revision surgery or – for the first time in this report – another reoperation. Chapter 6 briefly summarises the contents.

The 2020 Annual Report is available to download here.